Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences


Featured Articles

Current Status of Analytical Techniques for Characterization of Protein Stability

Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning

Bringing the Freezing of Biopharmaceuticals in From the Cold

Enabling Total Biopharma Solutions

Pall Life Sciences

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

View All Featured Articles

Headline News

Sofe-M combination shows 79% response rate in platinum-sensitive ovarian cancer


Incyte reports new KRAS G12D and bispecific antibody data across pancreatic and colorectal cancer


Pfizer’s 25-valent pneumococcal vaccine shows robust immune responses in Phase II infant study


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Impact of Depth Filtration on Disulfide Bond Reduction during Downstream Processing of Monoclonal Antibodies from CHO Cell Cultures

Presented by Brian O' Mara, Senior Research Scientist I at Bristol-Myers Squibb and Alexei Voloshin, Global Application Strategy Specialist at 3M Separation and Purification Sciences Division
08th October 2018


Innovation in Biomanufacturing Plants

Presented by Chris Chen PhD, CEO at WuXi Biologics and Dr. Sébastien Ribault, Senior Director, Global Delivery and Sales, BioReliance® End-to-End Solutions at Merck.
20th June 2019


A risk based approach to continuous processing

Presented by Rob Bowen, Chair of the UK Central Region of ISPE and co-chair of the ISPE HVAC and Sustainable Facilities Community of Practice.Process Architect and Director,Facilities Integration
14th May 2015


View All Past Webinars

Featured Companies

 

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

 

View All Videos

Technical Papers

Best Practices for Achieving Virus Safety


Column Packing Protocol for Amsphere A3


Amsphere TM A3


Read All Technical Papers

Featured Products

Decrease Cleaning Validation Time and Resources


AdvantaPure


Amsphere™ A3 Protein A Resin – JSR Life Sciences


View All Products

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia